Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 16/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 13/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 13/20 | 0.48 |
| ▸ | QSOX1 | O00391 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6249390 | 1.00 | SLC6A4 (0.48) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6245132 | 0.87 | SLC6A4 (0.64) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6245136 | 0.87 | SLC6A4 (0.64) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6245138 | 0.87 | SLC6A4 (0.64) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6247959 | 0.86 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6247961 | 0.86 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6247955 | 0.86 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6246784 | 0.84 | SLC6A4 (0.55) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6246785 | 0.84 | SLC6A4 (0.55) | SLC6A4SLC6A2SLC6A3QSOX1 | |
| SCHEMBL6246786 | 0.84 | SLC6A4 (0.55) | SLC6A4SLC6A2SLC6A3QSOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1157002-B1 | 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY | PFIZER LTD (GB) | 2005-08-10 | — | — | EP | disclosed |